Antibody boosts effectiveness of leukemia treatment Telemanagement Researchers at the University of Texas M.D. Anderson Cancer Center have been treating a group of 202 patients with CLL with standard chemotherapy plus the monoclonal antibody rituximab. They find a complete remission rate of 69 per cent, which is the ... |
